HTBX - Heat Biologics' unit Scorpion Kansas state to develop biodefense-focused manufacturing facility

Heat Biologics (NYSE:HTBX) said its unit Scorpion Biological Services, a private developer, the state of Kansas and local and university affiliates will develop a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas. The company said Manhattan is the home of Kansas State University, its Biosecurity Research Institute, and the National Bio and Agro-Defense Facility. Heat Biologics (HTBX) plans to use the new 500K+ square foot facility for large molecule and biologics manufacturing, with main focus on biodefense. Besides servicing the company’s own product pipeline, it plans to operate as a full-service Contract Development and Manufacturing Organization to provide third-party manufacturing services. Once fully operational, the new facility is expected to employ more than 500 people. HTBX +5.36% premarket to $2.95

For further details see:

Heat Biologics’ unit Scorpion, Kansas state to develop biodefense-focused manufacturing facility